Bloodstream infections due to Candida species in the intensive care unit: identifying especially high-risk patients to determine prevention strategies.
about
T2MR and T2Candida: novel technology for the rapid diagnosis of candidemia and invasive candidiasisPurpurin triggers caspase-independent apoptosis in Candida dubliniensis biofilmsNosocomial candidemia; risk factors and prognosis revisited; 11 years experience from a Norwegian secondary hospitalEpidemiology of invasive candidiasis: a persistent public health problemA quick and low-cost PCR-based assay for Candida spp. identification in positive blood culture bottles.Comparative evaluation of (1, 3)-beta-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia.Surveillance of Candida spp bloodstream infections: epidemiological trends and risk factors of death in two Mexican tertiary care hospitalsSphingolipid biosynthetic pathway genes FEN1 and SUR4 modulate amphotericin B resistance.Adaptation of Candida albicans to environmental pH induces cell wall remodelling and enhances innate immune recognition.Purine Acquisition and Synthesis by Human Fungal Pathogens.Caenorhabditis elegans-based model systems for antifungal drug discovery.Antifungal drug discovery through the study of invertebrate model hosts.Purpurin suppresses Candida albicans biofilm formation and hyphal development.Study on the effect of neem (Azadirachta indica A. juss) leaf extract on the growth of Aspergillus parasiticus and production of aflatoxin by it at different incubation times.Inhibition of nucleic acid biosynthesis makes little difference to formation of amphotericin B-tolerant persisters in Candida albicans biofilmSeptic shock due to candidemia: outcomes and predictors of shock development.The role of Candida albicans SPT20 in filamentation, biofilm formation and pathogenesis.Potent Antifungal Activity of Pure Compounds from Traditional Chinese Medicine Extracts against Six Oral Candida Species and the Synergy with Fluconazole against Azole-Resistant Candida albicansInhibitory Effect of Sophorolipid on Candida albicans Biofilm Formation and Hyphal Growth.Inhibition of Candida albicans Biofilm Formation by the Synthetic Lactoferricin Derived Peptide hLF1-11.Candida dubliniensis bloodstream infection: a fatal case in a lung transplant recipient.T cells from patients with Candida sepsis display a suppressive immunophenotypeRisks and benefits associated with antibiotic use for acute respiratory infections: a cohort study.Metastatic endophthalmitis.Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016.Molecular Insights into the Fungus-Specific Serine/Threonine Protein Phosphatase Z1 in Candida albicansTreatment of invasive fungal infections in cancer patients-updated recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).Anidulafungin versus caspofungin in a mouse model of candidiasis caused by anidulafungin-susceptible Candida parapsilosis isolates with different degrees of caspofungin susceptibilityTissue penetration of antifungal agents.Diagnosis and treatment of fungal infections in allogeneic stem cell and solid organ transplant recipients.Antifungals to treat Candida albicans.Design and use of Candida scores at the intensive care unit.Diagnosis and therapy of Candida infections: joint recommendations of the German Speaking Mycological Society and the Paul-Ehrlich-Society for Chemotherapy.Antifungal susceptibility of Candida albicans in biofilms.Candida peritonitis: an update on the latest research and treatments.Nosocomial Candidiasis: Antifungal Stewardship and the Importance of Rapid Diagnosis.Whole animal HTS of small molecules for antifungal compounds.Asarones from Acorus calamus in combination with azoles and amphotericin B: a novel synergistic combination to compete against human pathogenic Candida species in vitro.Cell density and cell aging as factors modulating antifungal resistance of Candida albicans biofilms.Evidence for a pseudo-outbreak of Candida guilliermondii fungemia in a university hospital in Brazil.
P2860
Q28084998-80D7450D-9903-4FEC-8586-85463EB1ACFFQ28537918-A184F462-93E4-44D2-8CD6-5C29700902D1Q28541447-0FEA8C4A-2E8E-42EB-BAD7-F46B42558685Q29616758-6A7AAE40-659D-49C7-A7F2-62FFAE65A92AQ31140994-1634BEA0-EE6E-4E1F-840D-F4DC24DF8468Q33296907-211CC73D-A8E2-429F-B3C1-58E4C7990506Q33618418-862D8EF0-9A4C-4426-93A1-7316C5119319Q33622748-C72F18FE-66EF-427C-BBFE-7971E2D5988DQ33758039-C17B8955-74B9-4295-A3DD-516F8389A3F4Q33845440-59ADFE3B-E8BE-4DAD-B06F-19887F524C45Q33864072-2742B837-FF55-4413-932D-9F127F3A5AB2Q34002069-7988CF34-1429-48BD-9D5C-7724F83EDE48Q34506049-27474EB7-E22C-4D6F-AF03-8323BFFB59ECQ34724824-70545285-B015-434D-8953-6E0EED8C4DEDQ35076919-C2EBC53E-5F24-41F4-A092-BD088B54C9FEQ35119972-C007DD2C-BDB7-4037-AE60-5444AEE07B0EQ35147589-DE56A2BF-DE64-4155-9522-585105C50180Q35794052-139252F0-61F8-477D-B315-F45A6CEB089EQ35974693-F26AA160-8E28-4597-AE92-134E8D4E81DFQ36208305-50D5710C-42E4-4AA2-BEFF-82AE634C506DQ36359387-B017B136-ABE4-400F-9016-95BFB7E7B5D1Q36480729-666DA5F6-0301-47E9-B4F0-DFD2265099FAQ36695717-FB67536E-7A4A-48BF-BC29-CE78CA665485Q36937106-E4EA2844-E752-40CD-A77D-D4FBA2892F3DQ37150434-393348A2-8FE8-42A3-91B3-BAA2C58B33D2Q37208359-F06EC4D3-9A8A-425E-AD9B-5B444531151DQ37469829-970A9824-59AF-4A0B-AF06-1FC63D62A443Q37544444-01C6F9AB-F028-4770-B5F7-F952103B35BBQ37544911-21FBB4F0-90CA-43FE-B652-C1661F39342DQ37650317-B9799AE9-46BE-4101-BA79-51EED4D728E5Q37763928-B97DBD04-B217-4FB8-85DA-7EE3D359F38DQ37871069-EE548FCF-4E5E-4C09-9F4F-D3D68D890DFFQ37889382-D5BD88D7-D328-467E-8DF1-27A2B11B894CQ37906758-895F5C03-7817-4331-A7D0-5FE6742CB2DBQ37942794-38EE4C6E-CEE6-4F64-B6FC-E8FFE88C9704Q38589279-7A84EFB7-FA89-4F85-A224-53C2D7EC5307Q38642986-9BEFDDD4-57F3-4E06-AD5E-73EE400C6105Q41480785-A7976495-B826-4D46-8E4A-2BB087F369EBQ42111899-7034E818-325F-45F6-AC6B-C93C07C1005AQ42128611-F8F39198-D315-46A8-AC84-4AC8598E4DB1
P2860
Bloodstream infections due to Candida species in the intensive care unit: identifying especially high-risk patients to determine prevention strategies.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Bloodstream infections due to ...... termine prevention strategies.
@en
Bloodstream infections due to ...... termine prevention strategies.
@nl
type
label
Bloodstream infections due to ...... termine prevention strategies.
@en
Bloodstream infections due to ...... termine prevention strategies.
@nl
prefLabel
Bloodstream infections due to ...... termine prevention strategies.
@en
Bloodstream infections due to ...... termine prevention strategies.
@nl
P2860
P356
P1476
Bloodstream infections due to ...... termine prevention strategies.
@en
P2093
Chris Gennings
Richard P Wenzel
P2860
P304
P356
10.1086/430923
P407
P478
41 Suppl 6
P577
2005-09-01T00:00:00Z